Rare Incidence of Congestive Heart Failure in Gastrointestinal Stromal Tumor and Other Sarcoma Patients Receiving Imatinib Mesylate (IM)

BACKGROUND: We sought to determine the incidence and severity of cardiovascular toxicity due to imatinib mesylate(IM) in GIST and other sarcoma patients, and to explore cardiotoxicity due to IM using cell culture and in vitro models. METHODS: To determine the incidence and significance of serious ca...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer
Autori principali: Trent, Jonathan C., Patel, Shalin S., Zhang, Jianhu, Araujo, Dejka M., Plana, Juan-Carlos, Lenihan, Daniel J., Fan, Dominic, Patel, Shreyaskumar R., Benjamin, Robert S., Khakoo, Aarif Y.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4306337/
https://ncbi.nlm.nih.gov/pubmed/19885836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24683
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi